NAGE
Niagen Bioscience, Inc.
NASDAQ: NAGE · HEALTHCARE · BIOTECHNOLOGY
$4.76
-1.65% today
Updated 2026-04-29
Market cap
$381.18M
P/E ratio
23.80
P/S ratio
2.95x
EPS (TTM)
$0.20
Dividend yield
—
52W range
$4 – $15
Volume
1.2M
Niagen Bioscience, Inc. (NAGE) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
8 of 8
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
+16.2%
Most recent quarter
EPS YoY growth
-69.3%
Most recent quarter
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-6.3%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-7.7%
2026-03-11
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-11 | $0.03 | +25.5% | $5.22 | $4.82 | -7.7% |
| 2025-11-04 | $0.05 | +150.0% | $7.23 | $6.88 | -4.8% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.02 | $0.03 | +25.5% | $33.84M | +16.2% |
| 2025-09-30 | $0.02 | $0.05 | +150.0% | $33.99M | +32.9% |
| 2025-06-30 | $0.02 | $0.04 | +100.0% | $31.12M | +36.8% |
| 2025-03-31 | $0.02 | $0.06 | +200.0% | $30.48M | +37.6% |
| 2024-12-31 | $0.02 | $0.09 | +350.0% | $29.13M | +37.4% |
| 2024-09-30 | $0.01 | $0.02 | +100.0% | $25.58M | +31.2% |
| 2024-06-30 | $-0.02 | $0.02 | +178.5% | $22.74M | +11.9% |
| 2024-03-31 | $-0.02 | $-0.01 | +50.0% | $22.15M | -1.8% |
| 2023-12-31 | $-0.02 | $0.00 | +106.7% | $21.20M | — |
| 2023-09-30 | $-0.03 | $-0.01 | +66.7% | $19.50M | — |
| 2023-06-30 | $-0.04 | $-0.03 | +25.0% | $20.32M | — |
| 2023-03-31 | $-0.04 | $-0.03 | +25.0% | $22.56M | — |
Frequently asked questions
Has Niagen Bioscience, Inc. beaten earnings estimates?
Niagen Bioscience, Inc. has beaten Wall Street EPS estimates in 8 of its last 8 quarterly reports.
How does NAGE stock react to earnings?
NAGE stock has moved an average of -6.3% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Niagen Bioscience, Inc.'s revenue growth rate?
Niagen Bioscience, Inc. reported year-over-year revenue growth of +16.2% in its most recent quarter, with EPS growing -69.3% year-over-year.